
Thurman Michael Wheeler
Examiner (ID: 17510, Phone: (571)270-1307 , Office: P/1619 )
| Most Active Art Unit | 1619 |
| Art Unit(s) | 1619 |
| Total Applications | 728 |
| Issued Applications | 283 |
| Pending Applications | 72 |
| Abandoned Applications | 384 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13458057
[patent_doc_number] => 20180280571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => ORTHOPEDIC IMPLANT HAVING A CRYSTALLINE CALCIUM PHOSPHATE COATING AND METHODS FOR MAKING THE SAME
[patent_app_type] => utility
[patent_app_number] => 15/472189
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22575
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15472189
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/472189 | Orthopedic implant having a crystalline calcium phosphate coating and methods for making the same | Mar 27, 2017 | Issued |
Array
(
[id] => 16769633
[patent_doc_number] => 10980715
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-20
[patent_title] => Gel composition, cosmetic, and method for producing gel composition
[patent_app_type] => utility
[patent_app_number] => 16/088759
[patent_app_country] => US
[patent_app_date] => 2017-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6902
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16088759
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/088759 | Gel composition, cosmetic, and method for producing gel composition | Mar 23, 2017 | Issued |
Array
(
[id] => 11713445
[patent_doc_number] => 20170181944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'Cleansing Composition'
[patent_app_type] => utility
[patent_app_number] => 15/456633
[patent_app_country] => US
[patent_app_date] => 2017-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2216
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15456633
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/456633 | Cleansing composition | Mar 12, 2017 | Issued |
Array
(
[id] => 11713480
[patent_doc_number] => 20170181978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'POLYMER PROTEIN MICROPARTICLES'
[patent_app_type] => utility
[patent_app_number] => 15/450335
[patent_app_country] => US
[patent_app_date] => 2017-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11871
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15450335
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/450335 | Polymer protein microparticles | Mar 5, 2017 | Issued |
Array
(
[id] => 16335591
[patent_doc_number] => 10786529
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-29
[patent_title] => Oral cholestyramine formulation and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/449779
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 10117
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449779
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/449779 | Oral cholestyramine formulation and use thereof | Mar 2, 2017 | Issued |
Array
(
[id] => 16755281
[patent_doc_number] => 10973807
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-13
[patent_title] => Pharmaceutical composition comprising pyrrolo-fused six-membered heterocyclic compound
[patent_app_type] => utility
[patent_app_number] => 16/079589
[patent_app_country] => US
[patent_app_date] => 2017-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 2761
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16079589
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/079589 | Pharmaceutical composition comprising pyrrolo-fused six-membered heterocyclic compound | Feb 27, 2017 | Issued |
Array
(
[id] => 11935007
[patent_doc_number] => 20170239156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'HAIR SHAPE CONTROL ASSISTING AGENT'
[patent_app_type] => utility
[patent_app_number] => 15/440645
[patent_app_country] => US
[patent_app_date] => 2017-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6098
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15440645
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/440645 | HAIR SHAPE CONTROL ASSISTING AGENT | Feb 22, 2017 | Abandoned |
Array
(
[id] => 12125133
[patent_doc_number] => 20180008719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'POLYMERIC DRUG CONJUGATES WITH TETHER GROUPS FOR CONTROLLED DRUG DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 15/434431
[patent_app_country] => US
[patent_app_date] => 2017-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 32689
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15434431
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/434431 | POLYMERIC DRUG CONJUGATES WITH TETHER GROUPS FOR CONTROLLED DRUG DELIVERY | Feb 15, 2017 | Abandoned |
Array
(
[id] => 13925895
[patent_doc_number] => 20190046463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME
[patent_app_type] => utility
[patent_app_number] => 16/077355
[patent_app_country] => US
[patent_app_date] => 2017-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9241
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16077355
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/077355 | Transdermal UV-curable hydrogel resin, hydrogel curing the same and cataplasm containing the same | Jan 31, 2017 | Issued |
Array
(
[id] => 11820621
[patent_doc_number] => 20170209559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'Polymer-Protein Core-Shell Particles as Effective Vaccine Delivery Vehicles and Treatments Methods Using the Same'
[patent_app_type] => utility
[patent_app_number] => 15/416429
[patent_app_country] => US
[patent_app_date] => 2017-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 4429
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15416429
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/416429 | Polymer-protein core-shell particles as effective vaccine delivery vehicles and treatments methods using the same | Jan 25, 2017 | Issued |
Array
(
[id] => 11820417
[patent_doc_number] => 20170209354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'MULTILAMELLAR VESICLE PREPARATION CONTAINING ACYL BASIC AMINO ACID DERIVATIVE AND PHYSIOLOGICALLY ACTIVE SUBSTANCE'
[patent_app_type] => utility
[patent_app_number] => 15/409219
[patent_app_country] => US
[patent_app_date] => 2017-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5912
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15409219
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/409219 | MULTILAMELLAR VESICLE PREPARATION CONTAINING ACYL BASIC AMINO ACID DERIVATIVE AND PHYSIOLOGICALLY ACTIVE SUBSTANCE | Jan 17, 2017 | Abandoned |
Array
(
[id] => 11755822
[patent_doc_number] => 20170202689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'PREFORM PRODUCED BY ELECTROSPINNING, METHOD FOR PRODUCING THE SAME AND USE OF SUCH A PREFORM'
[patent_app_type] => utility
[patent_app_number] => 15/405469
[patent_app_country] => US
[patent_app_date] => 2017-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3353
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15405469
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/405469 | Preform produced by electrospinning, method for producing the same and use of such a preform | Jan 12, 2017 | Issued |
Array
(
[id] => 11602439
[patent_doc_number] => 20170119739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'METHOD FOR IMPROVING PHARMACOKINETICS'
[patent_app_type] => utility
[patent_app_number] => 15/404398
[patent_app_country] => US
[patent_app_date] => 2017-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7469
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15404398
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/404398 | METHOD FOR IMPROVING PHARMACOKINETICS | Jan 11, 2017 | Abandoned |
Array
(
[id] => 12157283
[patent_doc_number] => 20180028548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/550779
[patent_app_country] => US
[patent_app_date] => 2017-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6171
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15550779
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/550779 | Pharmaceutical compositions | Jan 11, 2017 | Issued |
Array
(
[id] => 11742224
[patent_doc_number] => 20170196296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'Amphoteric Metal Compound-Treated Substrate And Methods For Reduction Of Body Odor Using Treated Substrates'
[patent_app_type] => utility
[patent_app_number] => 15/403929
[patent_app_country] => US
[patent_app_date] => 2017-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8304
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15403929
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/403929 | Amphoteric Metal Compound-Treated Substrate And Methods For Reduction Of Body Odor Using Treated Substrates | Jan 10, 2017 | Abandoned |
Array
(
[id] => 11588528
[patent_doc_number] => 20170112939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'PREVENTION AND TREATMENT OF OCULAR CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/400887
[patent_app_country] => US
[patent_app_date] => 2017-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37836
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15400887
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/400887 | PREVENTION AND TREATMENT OF OCULAR CONDITIONS | Jan 5, 2017 | Abandoned |
Array
(
[id] => 13805201
[patent_doc_number] => 10179862
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-15
[patent_title] => Optically clear biofouling resistant compositions and methods for marine instruments
[patent_app_type] => utility
[patent_app_number] => 15/400855
[patent_app_country] => US
[patent_app_date] => 2017-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7653
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15400855
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/400855 | Optically clear biofouling resistant compositions and methods for marine instruments | Jan 5, 2017 | Issued |
Array
(
[id] => 12210988
[patent_doc_number] => 09907780
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-06
[patent_title] => 'Low-dose doxepin formulations and methods of making and using the same'
[patent_app_type] => utility
[patent_app_number] => 15/394912
[patent_app_country] => US
[patent_app_date] => 2016-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 19804
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15394912
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/394912 | Low-dose doxepin formulations and methods of making and using the same | Dec 29, 2016 | Issued |
Array
(
[id] => 16215114
[patent_doc_number] => 10730912
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-04
[patent_title] => Template-fixed peptidomimetics with antimicrobial activity
[patent_app_type] => utility
[patent_app_number] => 15/392586
[patent_app_country] => US
[patent_app_date] => 2016-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26484
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 665
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15392586
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/392586 | Template-fixed peptidomimetics with antimicrobial activity | Dec 27, 2016 | Issued |
Array
(
[id] => 17783479
[patent_doc_number] => 11406580
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-09
[patent_title] => Use of dihydroisoquinolinium salts for treating keratin materials, compositions and implementation processes
[patent_app_type] => utility
[patent_app_number] => 16/064256
[patent_app_country] => US
[patent_app_date] => 2016-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7166
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 327
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16064256
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/064256 | Use of dihydroisoquinolinium salts for treating keratin materials, compositions and implementation processes | Dec 22, 2016 | Issued |